Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID‐19 infection

Cancer patients are considered highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. However, it is not well known when chemotherapy can be safely restarted in cancer patients after coronavirus disease 2019 (COVID‐19). Here, we describe the case of an 18‐year‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanabe, Yuki, Shukuya, Takehito, Nagata, Yuichi, Watanabe, Takayasu, Seto, Koichi, Takahashi, Rina, Masuda, Koichi, Miura, Keita, Tajima, Ken, Hiki, Makoto, Hayashi, Takuo, Suzuki, Kenji, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353416/
https://www.ncbi.nlm.nih.gov/pubmed/35903864
http://dx.doi.org/10.1111/1759-7714.14593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353416/
https://www.ncbi.nlm.nih.gov/pubmed/35903864
http://dx.doi.org/10.1111/1759-7714.14593

Ejemplares similares